This is not the most recent version of the article. View current version (7 OCT 2009)

Intervention Protocol

Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer

  1. Chao Ma1,*,
  2. Jiawei Xie2,
  3. Qingfeng Chen3,
  4. Guoming Wang4,
  5. Shuyao Zuo4

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 8 JUL 2009

DOI: 10.1002/14651858.CD007956

Database Title

Additional Information

How to Cite

Ma C, Xie J, Chen Q, Wang G, Zuo S. Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007956. DOI: 10.1002/14651858.CD007956.

Author Information

  1. 1

    Affiliated Hospital of Medical College Qingdao University, Department of Nuclear Medicine, Qingdao, Shandong Province, China

  2. 2

    Affiliated Hospital, Stomatology, Qingdao, Shandong, China

  3. 3

    Affiliated Hospital, Surgery, Qingdao, Shandong, China

  4. 4

    Affiliated Hospital, Nuclear Medicine, Qingdao, Shandong, China

*Chao Ma, Department of Nuclear Medicine, Affiliated Hospital of Medical College Qingdao University, Jiangsu Road 16, Qingdao, Shandong Province, 266003, China. machaopony@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 8 JUL 2009

SEARCH

ARTICLE TOOLS

This is not the most recent version of the article.View current version (07 Oct 2009)

View Full Article (HTML) Full (227K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of amifostine on salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer.

View Full Article (HTML) Full (227K)